EAST RUTHERFORD, N.J., Aug. 26, 2016-- Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, is pleased to announce that company management ...
- Motley Fool•4 days ago
Each of the healthcare stocks in this batch has given investors at least a seven-bagger in the last five years -- and each one expects the growth to continue.
- Capital Cube•5 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Cambrex Corp. Here are 5 ETF’s with the largest exposure to CBM-US. Comparing the performance and risk of Cambrex Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Cambrex Corporation (CBM)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||44.00 x 1000|
|Ask||44.01 x 500|
|Day's Range||43.51 - 44.49|
|52wk Range||29.50 - 59.41|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||22.25|
|Avg Vol (3m)||390,209|
|Dividend & Yield||0.00 (0.00%)|